Skip to main content
SpringerLink
Log in

Antineoplastics

Drug resistance and lack of efficacy : case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Noguchi K, et al. Acquired L1196M ALK mutation in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma during alectinib administration. eJHaem 4: 305-308, No. 1, Feb 2023. Available from: URL: http://doi.org/10.1002/jha2.646

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Antineoplastics. Reactions Weekly 1953, 44 (2023). https://doi.org/10.1007/s40278-023-37479-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-37479-3

Search

Navigation